发明名称 Compounds for the management of aging-related and diabetic vascular complications, process for their preparation, therapeutic and cosmetic uses thereof
摘要 The invention discloses a new clause of a five membered heterocylic ring compounds of general formula I and its pharmaceutically or cosmetically acceptable salts, wherein R1, R2, R3, R4, R5, A, B, X and Y are as defined in the specification. The invention also discloses a process for preparation of these compound and their therapeutic and cosmetic applications particularly in the management of aging related and diabetic vascular complications. The compounds in question act by triple action of an AGE (Advanced Glycation Endproducts) breaker, AGE inhibitor and free radical scavenger which make them most suitable in different therapeutic and cosmetic applications. The invention also discloses pharmaceuticals and cosmetic compositions comprising these compounds and method of treatment of diseases caused by accumulation of AGE and/or free radicals in the body cells.
申请公布号 US7223777(B2) 申请公布日期 2007.05.29
申请号 US20020116135 申请日期 2002.04.05
申请人 TORRENT PHARMACEUTICALS LTD. 发明人 SANKARANARAYANAN ALANGUDI
分类号 A61K31/4439;C07D401/04;A61K8/00;A61K8/49;A61K31/4427;A61K31/4436;A61K31/4545;A61K31/4709;A61P1/00;A61P1/16;A61P3/00;A61P9/10;A61P11/00;A61P13/12;A61P15/10;A61P25/00;A61P25/28;A61P27/02;A61P29/00;A61P31/18;A61P35/00;A61P37/02;A61P39/06;A61P43/00;A61Q17/04;A61Q19/00;A61Q19/08;C07D401/14;C07D409/04;C07D409/14;C07D411/04;C07D413/04;C07D413/14 主分类号 A61K31/4439
代理机构 代理人
主权项
地址